Skip to main content

ADVERTISEMENT

health care cost

Research in Review
08/15/2017
JCP Editors
A recent comparative effectiveness study examined the relationship of anticitrullinated protein antibody (ACPA) status and accrued economic burden for patients with rheumatoid arthritis, published in the Journal of...
A recent comparative effectiveness study examined the relationship of anticitrullinated protein antibody (ACPA) status and accrued economic burden for patients with rheumatoid arthritis, published in the Journal of...
A...
08/15/2017
Journal of Clinical Pathways
Research in Review
07/19/2017
JCP Editors
Recent research suggests that 73% of patients with cancer do not discuss the cost of care with their care team, published by the Cancer Support Community (July 18, 2017). ----- Related Content Improving Patient...
Recent research suggests that 73% of patients with cancer do not discuss the cost of care with their care team, published by the Cancer Support Community (July 18, 2017). ----- Related Content Improving Patient...
Recent...
07/19/2017
Journal of Clinical Pathways
Research in Review
06/28/2017
JCP Editors
A cost-effectiveness analysis assessed oral fentanyl formulations available for the treatment of breakthrough cancer pain, published in PLOS One (published online June 27, 2017;...
A cost-effectiveness analysis assessed oral fentanyl formulations available for the treatment of breakthrough cancer pain, published in PLOS One (published online June 27, 2017;...
A...
06/28/2017
Journal of Clinical Pathways
Research in Review
06/13/2017
JCP Editors
Mitigation strategies may save up to 17% annually in parenteral anticancer drug costs, according to a study published in the Journal of Oncology Practice (published online June 12, 2017;...
Mitigation strategies may save up to 17% annually in parenteral anticancer drug costs, according to a study published in the Journal of Oncology Practice (published online June 12, 2017;...
...
06/13/2017
Journal of Clinical Pathways
Research in Review
06/03/2017
JCP Editors
Financial toxicity and excessive financial burden appeared common among melanoma survivors, frequently leading to disease-related distress, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...
Financial toxicity and excessive financial burden appeared common among melanoma survivors, frequently leading to disease-related distress, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...
...
06/03/2017
Journal of Clinical Pathways
Research in Review
05/31/2017
JCP Editors
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women...
05/31/2017
Journal of Clinical Pathways
Department
04/12/2017
JCP Editors
Many patients receive immunotherapy prescriptions for off-label treatment, potentially contributing to unnecessary health care expenditures.  ----- Related Content Cost-Effective Immunotherapy Treatments for...
Many patients receive immunotherapy prescriptions for off-label treatment, potentially contributing to unnecessary health care expenditures.  ----- Related Content Cost-Effective Immunotherapy Treatments for...
Many...
04/12/2017
Journal of Clinical Pathways
Interview
03/27/2017
JCP Editors
Journal of Clinical Pathways spoke with Alex W Bastian, MBA, strategic advisor, ASCO Value In Cancer Task Force, about how his role in the Task Force has impacted his views concerning...
Journal of Clinical Pathways spoke with Alex W Bastian, MBA, strategic advisor, ASCO Value In Cancer Task Force, about how his role in the Task Force has impacted his views concerning...
...
03/27/2017
Journal of Clinical Pathways